By Professor Glenda Halliday

Journal articles

Nelson PT; Lee EB; Cykowski MD; Alafuzoff I; Arfanakis K; Attems J; Brayne C; Corrada MM; Dugger BN; Flanagan ME; Ghetti B; Grinberg LT; Grossman M; Grothe MJ; Halliday GM; Hasegawa M; Hokkanen SRK; Hunter S; Jellinger K; Kawas CH; Keene CD; Kouri N; Kovacs GG; Leverenz JB; Latimer CS; Mackenzie IR; Mao Q; McAleese KE; Merrick R; Montine TJ; Murray ME; Myllykangas L; Nag S; Neltner JH; Newell KL; Rissman RA; Saito Y; Sajjadi SA; Schwetye KE; Teich AF; Thal DR; Tomé SO; Troncoso JC; Wang SHJ; White CL; Wisniewski T; Yang HS; Schneider JA; Dickson DW; Neumann M, 2023, 'LATE-NC staging in routine neuropathologic diagnosis: an update', Acta Neuropathologica, 145, pp. 159 - 173, http://dx.doi.org/10.1007/s00401-022-02524-2

Fu YH; Zhou L; Li H; Hsiao J; Li B; Tanglay O; Auwyang AD; Wang E; Feng J; Kim WS; Liu J; Halliday GM, 2023, 'Correction to: Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease (Acta Neuropathologica, (2022), 144, 5, (861-879), 10.1007/s00401-022-02488-3)', Acta Neuropathologica, 145, pp. 157, http://dx.doi.org/10.1007/s00401-022-02523-3

Tse NY; Bocchetta M; Todd EG; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Kiernan MC; Piguet O; Rohrer JD; Ahmed RM, 2023, 'Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum', NeuroImage: Clinical, 37, http://dx.doi.org/10.1016/j.nicl.2022.103281

Labrador-Garrido A; Zhong S; Hughes L; Keshiya S; Kim WS; Halliday GM; Dzamko N, 2023, 'Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations', Frontiers in Cellular Neuroscience, 17, http://dx.doi.org/10.3389/fncel.2023.1229213

Phan K; He Y; Bhatia S; Pickford R; Mcdonald G; Mazumder S; Timmins HC; Hodges JR; Piguet O; Dzamko N; Halliday GM; Kiernan MC; Kim WS, 2023, 'Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis', Brain Communications, 5, http://dx.doi.org/10.1093/braincomms/fcac340

Hwang YT; Halliday GM; Piguet O; Burrell JR, 2023, 'Assessing utility of imaging based biomarker to differentiate pathologically classified frontotemporal lobar degeneration syndromes', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.075559

McCann H; Halliday GM; Shepherd CE, 2023, 'The relationship between traumatic brain injury and the neuropathology of dementia', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.061668

Fumagalli GG; Sorrentino F; de Boer SCM; Riedl L; Landin‐Romero R; Matis S; Southwood D; Chatterton Z; Diehl‐Schmid J; Halliday GM; Ducharme S; Piguet O; Pijnenburg YAL; Galimberti D, 2023, 'Visual rating scales of atrophy to differentiate Frontotemporal dementia from Primary psychiatric disorder: results from DIPPA study', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.073286

Fumagalli GG; Sorrentino F; de Boer SCM; Riedl L; Landin‐Romero R; Matis S; Southwood D; Chatterton Z; Diehl‐Schmid J; Halliday GM; Ducharme S; Piguet O; Pijnenburg YAL; Galimberti D, 2023, 'Visual rating scales of atrophy to differentiate Frontotemporal dementia from Primary psychiatric disorder: results from DIPPA study', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.081607

Matar E; Ehgoetz Martens KA; Phillips JR; Wainstein G; Halliday GM; Lewis SJG; Shine JM, 2022, 'Dynamic network impairments underlie cognitive fluctuations in Lewy body dementia', npj Parkinson's Disease, 8, http://dx.doi.org/10.1038/s41531-022-00279-x

Ahmadi Rastegar D; Hughes LP; Perera G; Keshiya S; Zhong S; Gao J; Halliday GM; Schüle B; Dzamko N, 2022, 'Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages', npj Parkinson's Disease, 8, http://dx.doi.org/10.1038/s41531-022-00297-9

Phillips JR; Matar E; Ehgoetz Martens KA; Moustafa AA; Halliday GM; Lewis SJG, 2022, 'Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria', Brain Sciences, 12, http://dx.doi.org/10.3390/brainsci12121594

Bitar M; Weissleder C; North HF; Clearwater MS; Zalucki O; Halliday GM; Webster MJ; Piper M; Weickert CS; Barry G, 2022, 'Identifying gene expression profiles associated with neurogenesis and inflammation in the human subependymal zone from development through aging', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-021-03976-4

Fu YH; He Y; Phan K; Bhatia S; Pickford R; Wu P; Dzamko N; Halliday GM; Kim WS, 2022, 'Increased unsaturated lipids underlie lipid peroxidation in synucleinopathy brain', Acta Neuropathologica Communications, 10, http://dx.doi.org/10.1186/s40478-022-01469-7

Poewe W; Stankovic I; Halliday G; Meissner WG; Wenning GK; Pellecchia MT; Seppi K; Palma JA; Kaufmann H, 2022, 'Multiple system atrophy', Nature Reviews Disease Primers, 8, http://dx.doi.org/10.1038/s41572-022-00382-6

Mazumder S; Kiernan MC; Halliday GM; Timmins HC; Mahoney CJ, 2022, 'The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review', Neuropathology and Applied Neurobiology, 48, http://dx.doi.org/10.1111/nan.12845

Fu YH; Zhou L; Li H; Hsiao JHT; Li B; Tanglay O; Auwyang AD; Wang E; Feng J; Kim WS; Liu J; Halliday GM, 2022, 'Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease', Acta Neuropathologica, 144, pp. 861 - 879, http://dx.doi.org/10.1007/s00401-022-02488-3

Katzeff JS; Lok HC; Bhatia S; Fu YH; Halliday GM; Kim WS, 2022, 'ATP-binding cassette transporter expression is widely dysregulated in frontotemporal dementia with TDP-43 inclusions', Frontiers in Molecular Neuroscience, 15, http://dx.doi.org/10.3389/fnmol.2022.1043127

Hopfner F; Tietz AK; Ruf VC; Ross OA; Koga S; Dickson D; Aguzzi A; Attems J; Beach T; Beller A; Cheshire WP; van Deerlin V; Desplats P; Deuschl G; Duyckaerts C; Ellinghaus D; Evsyukov V; Flanagan ME; Franke A; Frosch MP; Gearing M; Gelpi E; van Gerpen JA; Ghetti B; Glass JD; Grinberg LT; Halliday G; Helbig I; Höllerhage M; Huitinga I; Irwin DJ; Keene DC; Kovacs GG; Lee EB; Levin J; Martí MJ; Mackenzie I; McKeith I; Mclean C; Mollenhauer B; Neumann M; Newell KL; Pantelyat A; Pendziwiat M; Peters A; Molina Porcel L; Rabano A; Matěj R; Rajput A; Rajput A; Reimann R; Scott WK; Seeley W; Selvackadunco S; Simuni T; Stadelmann C; Svenningsson P; Thomas A; Trenkwalder C; Troakes C; Trojanowski JQ; Uitti RJ; White CL; Wszolek ZK; Xie T; Ximelis T; Yebenes J; Müller U; Schellenberg GD; Herms J; Kuhlenbäumer G; Höglinger G, 2022, 'Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy', Movement Disorders, 37, pp. 2110 - 2121, http://dx.doi.org/10.1002/mds.29164

Galper J; Dean NJ; Pickford R; Lewis SJG; Halliday GM; Kim WS; Dzamko N, 2022, 'Lipid pathway dysfunction is prevalent in patients with Parkinson's disease', Brain, 145, pp. 3472 - 3487, http://dx.doi.org/10.1093/brain/awac176

Trist BG; Genoud S; Roudeau S; Rookyard A; Abdeen A; Cottam V; Hare DJ; White M; Altvater J; Fifita JA; Hogan A; Grima N; Blair IP; Kysenius K; Crouch PJ; Carmona A; Rufin Y; Claverol S; Van Malderen S; Falkenberg G; Paterson DJ; Smith B; Troakes C; Vance C; Shaw CE; Al-Sarraj S; Cordwell S; Halliday G; Ortega R; Double KL, 2022, 'Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord', Brain, 145, pp. 3108 - 3130, http://dx.doi.org/10.1093/brain/awac165

Chedid J; Labrador-Garrido A; Zhong S; Gao J; Zhao Y; Perera G; Kim WS; Halliday GM; Dzamko N, 2022, 'A small molecule toll-like receptor antagonist rescues α-synuclein fibril pathology', Journal of Biological Chemistry, 298, http://dx.doi.org/10.1016/j.jbc.2022.102260

Johnson EG; Kuiper W; Ahmed RM; Halliday GM; Burrell JR; Hodges JR; Guastella AJ; Piguet O; Kumfor F, 2022, 'Plasma Oxytocin Is Not Associated with Social Cognition or Behavior in Frontotemporal Dementia and Alzheimer's Disease Syndromes', Dementia and Geriatric Cognitive Disorders, 51, pp. 241 - 248, http://dx.doi.org/10.1159/000525087

Tse NY; Tu S; Chen Y; Caga J; Dobson-Stone C; Kwok JB; Halliday GM; Ahmed RM; Hodges JR; Piguet O; Kiernan MC; Devenney EM, 2022, 'Schizotypal traits across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum: pathomechanistic insights', Journal of Neurology, 269, pp. 4241 - 4252, http://dx.doi.org/10.1007/s00415-022-11049-3

Foxe D; Hu A; Cheung SC; Ahmed RM; Cordato NJ; Devenney E; Hwang YT; Halliday GM; Mueller N; Leyton CE; Hodges JR; Burrell JR; Irish M; Piguet O, 2022, 'Utility of the Addenbrooke's Cognitive Examination III online calculator to differentiate the primary progressive aphasia variants', BRAIN COMMUNICATIONS, 4, http://dx.doi.org/10.1093/braincomms/fcac161

Phillips JR; Matar E; Ehgoetz Martens KA; Moustafa AA; Halliday GM; Lewis SJG, 2022, 'An Adaptive Measure of Visuospatial Impairment in Dementia with Lewy Bodies', Movement Disorders Clinical Practice, 9, pp. 619 - 627, http://dx.doi.org/10.1002/mdc3.13488

Weiss F; Labrador-Garrido A; Dzamko N; Halliday G, 2022, 'Immune responses in the Parkinson's disease brain', Neurobiology of Disease, 168, http://dx.doi.org/10.1016/j.nbd.2022.105700

Wenning GK; Stankovic I; Vignatelli L; Fanciulli A; Calandra-Buonaura G; Seppi K; Palma JA; Meissner WG; Krismer F; Berg D; Cortelli P; Freeman R; Halliday G; Höglinger G; Lang A; Ling H; Litvan I; Low P; Miki Y; Panicker J; Pellecchia MT; Quinn N; Sakakibara R; Stamelou M; Tolosa E; Tsuji S; Warner T; Poewe W; Kaufmann H, 2022, 'The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy', Movement Disorders, 37, pp. 1131 - 1148, http://dx.doi.org/10.1002/mds.29005

Katzeff JS; Bright F; Phan K; Kril JJ; Ittner LM; Kassiou M; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2022, 'Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis', Brain, 145, pp. 1598 - 1609, http://dx.doi.org/10.1093/brain/awac077

Boel JA; de Bie RMA; Schmand BA; Dalrymple-Alford JC; Marras C; Adler CH; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ; Bernard B; Stebbins G; Filoteo JV; Weintraub D; Caviness JN; Belden C; Zabetian CP; Cholerton BA; Huang X; Eslinger PJ; Leverenz JB; Duff-Canning S; Farrer M; Anderson TJ; Myall DJ; Naismith SL; Lewis SJG; Halliday GM; Wu RM; Williams-Gray CH; Breen DP; Barker RA; Yarnall AJ; Klein M; Mollenhauer B; Trenkwalder C; Kulisevsky J; Pagonabarraga J; Gasca-Salas C; Rodriguez-Oroz MC; Junque C; Segura B; Barone P; Santangelo G; Cammisuli DM; Biundo R; Antonini A; Weis L; Pedersen KF; Alves G, 2022, 'Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia', Movement Disorders Clinical Practice, 9, pp. 479 - 483, http://dx.doi.org/10.1002/mdc3.13451

Hooshmand K; Halliday GM; Pineda SS; Sutherland GT; Guennewig B, 2022, 'Overlap between Central and Peripheral Transcriptomes in Parkinson’s Disease but Not Alzheimer’s Disease', International Journal of Molecular Sciences, 23, http://dx.doi.org/10.3390/ijms23095200

Chen Y; Landin-Romero R; Kumfor F; Irish M; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR; Piguet O, 2022, 'Cerebellar integrity and contributions to cognition in C9orf72-mediated frontotemporal dementia', Cortex, 149, pp. 73 - 84, http://dx.doi.org/10.1016/j.cortex.2021.12.014

Matar E; Brooks D; Lewis SJG; Halliday GM, 2022, 'Limbic thalamus atrophy is associated with visual hallucinations in Lewy body disorders', Neurobiology of Aging, 112, pp. 122 - 128, http://dx.doi.org/10.1016/j.neurobiolaging.2022.01.001

Stevanovski I; Chintalaphani SR; Gamaarachchi H; Ferguson JM; Pineda SS; Scriba CK; Tchan M; Fung V; Ng K; Cortese A; Houlden H; Dobson-Stone C; Fitzpatrick L; Halliday G; Ravenscroft G; Davis MR; Laing NG; Fellner A; Kennerson M; Kumar KR; Deveson IW, 2022, 'Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing', Science Advances, 8, http://dx.doi.org/10.1126/sciadv.abm5386

Ferreira N; Richner M; van der Laan A; Jul Christiansen IB; Vaegter CB; Nyengaard JR; Halliday GM; Weis J; Giasson BI; Mackenzie IR; Jensen PH; Jan A, 2022, 'Correction: Prodromal neuroinvasion of pathological alpha-synuclein in brainstem reticular nuclei and white matter lesions in a model of alpha-synucleinopathy (vol 3, fcab104, 2021)', BRAIN COMMUNICATIONS, 4, http://dx.doi.org/10.1093/braincomms/fcac067

Bocchetta M; Todd EG; Tse NY; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Piguet O; Kiernan MC; Rohrer JD; Ahmed RM, 2022, 'Thalamic and Cerebellar Regional Involvement across the ALS–FTD Spectrum and the Effect of C9orf72', Brain Sciences, 12, http://dx.doi.org/10.3390/brainsci12030336

Ge P; Yang M; Bouchard JL; Dzamko N; Lewis SJG; Halliday GM; Doran TM, 2022, 'Chemoselective Bioconjugation of Amyloidogenic Protein Antigens to PEGylated Microspheres Enables Detection of α-Synuclein Autoantibodies in Human Plasma', Bioconjugate Chemistry, 33, pp. 301 - 310, http://dx.doi.org/10.1021/acs.bioconjchem.1c00530

Narasimhan M; Schwartz R; Halliday G, 2022, 'Parkinsonism and cerebrovascular disease', Journal of the Neurological Sciences, 433, http://dx.doi.org/10.1016/j.jns.2021.120011

Kumfor F; Liang CT; Hazelton JL; Leyton CE; Kaizik C; Devenney E; Connaughton E; Langdon R; Mioshi E; Kwok JB; Dobson-Stone C; Halliday GM; Piguet O; Hodges JR; Landin-Romero R, 2022, 'Examining the presence and nature of delusions in Alzheimer's disease and frontotemporal dementia syndromes', International Journal of Geriatric Psychiatry, 37, http://dx.doi.org/10.1002/gps.5692

Ehgoetz Martens KA; Matar E; Phillips JR; Shine JM; Grunstein RR; Halliday GM; Lewis SJG, 2022, 'Narrow doorways alter brain connectivity and step patterns in isolated REM sleep behaviour disorder', NeuroImage: Clinical, 33, http://dx.doi.org/10.1016/j.nicl.2022.102958

Mccann H; Bahar AY; Burkhardt K; Gardner AJ; Halliday GM; Iverson GL; Shepherd CE, 2022, 'Prevalence of chronic traumatic encephalopathy in the Sydney Brain Bank', Brain Communications, 4, pp. fcac189, http://dx.doi.org/10.1093/braincomms/fcac189

Fu Y; He Y; Phan K; Pickford R; Kim YB; Dzamko N; Halliday GM; Kim WS, 2022, 'Sex-specific lipid dysregulation in the Abca7 knockout mouse brain', Brain Communications, 4, http://dx.doi.org/10.1093/braincomms/fcac120

de Boer SCM; Riedl L; Van der lee SJ; Otto M; Anderl‐Straub S; Landin‐Romero R; Sorrentino F; Fieldhouse JLP; Reus LM; Halliday GM; Galimberti D; Diehl‐Schmid J; Ducharme S; Piguet O; Pijnenburg YAL, 2022, 'Shorter disease duration in females with sporadic frontotemporal dementia', Alzheimer's & Dementia, 18, http://dx.doi.org/10.1002/alz.067557

Phan K; He Y; Fu Y; Dzamko N; Bhatia S; Gold J; Rowe D; Ke YD; Ittner LM; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2021, 'Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia.', Commun Med (Lond), 1, pp. 60, http://dx.doi.org/10.1038/s43856-021-00060-w

Gregersen E; Betzer C; Kim WS; Kovacs G; Reimer L; Halliday GM; Thiel S; Jensen PH, 2021, 'Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity', Journal of Neuroinflammation, 18, http://dx.doi.org/10.1186/s12974-021-02225-9

Oliveira LMA; Gasser T; Edwards R; Zweckstetter M; Melki R; Stefanis L; Lashuel HA; Sulzer D; Vekrellis K; Halliday GM; Tomlinson JJ; Schlossmacher M; Jensen PH; Schulze-Hentrich J; Riess O; Hirst WD; El-Agnaf O; Mollenhauer B; Lansbury P; Outeiro TF, 2021, 'Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease', npj Parkinson's Disease, 7, http://dx.doi.org/10.1038/s41531-021-00203-9

Guennewig B; Lim J; Marshall L; McCorkindale AN; Paasila PJ; Patrick E; Kril JJ; Halliday GM; Cooper AA; Sutherland GT, 2021, 'Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology (Scientific Reports, (2021), 11, 1, (4865), 10.1038/s41598-021-83872-z)', Scientific Reports, 11, http://dx.doi.org/10.1038/s41598-021-97076-y

Aarsland D; Batzu L; Halliday GM; Geurtsen GJ; Ballard C; Ray Chaudhuri K; Weintraub D, 2021, 'Author Correction: Parkinson disease-associated cognitive impairment (Nature Reviews Disease Primers, (2021), 7, 1, (47), 10.1038/s41572-021-00280-3)', Nature Reviews Disease Primers, 7, http://dx.doi.org/10.1038/s41572-021-00292-z

Guennewig B; Lim J; Marshall L; McCorkindale AN; Paasila PJ; Patrick E; Kril JJ; Halliday GM; Cooper AA; Sutherland GT, 2021, 'Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology', Scientific Reports, 11, http://dx.doi.org/10.1038/s41598-021-83872-z

He Y; Phan K; Bhatia S; Pickford R; Fu YH; Yang Y; Hodges JR; Piguet O; Halliday GM; Kim WS, 2021, 'Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia', Scientific Reports, 11, http://dx.doi.org/10.1038/s41598-021-00870-x

Back to profile page